PAFAH1B3 antibody
-
- Target See all PAFAH1B3 Antibodies
- PAFAH1B3 (Platelet-Activating Factor Acetylhydrolase 1b, Catalytic Subunit 3 (29kDa) (PAFAH1B3))
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This PAFAH1B3 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Characteristics
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogen
- Fusion protein of human PAFAH1B3
- Isotype
- IgG
- Top Product
- Discover our top product PAFAH1B3 Primary Antibody
-
-
- Application Notes
- WB 1:1000-1:5000, IHC 1:50-1:200, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.2 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- PAFAH1B3 (Platelet-Activating Factor Acetylhydrolase 1b, Catalytic Subunit 3 (29kDa) (PAFAH1B3))
- Alternative Name
- PAFAH1B3 (PAFAH1B3 Products)
- Synonyms
- PAFAHG antibody, Pafahg antibody, mus[g] antibody, platelet activating factor acetylhydrolase 1b catalytic subunit 3 antibody, platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 antibody, platelet-activating factor acetylhydrolase, isoform 1b, subunit 3 antibody, PAFAH1B3 antibody, Pafah1b3 antibody
- Background
- This gene encodes an acetylhydrolase that catalyzes the removal of an acetyl group from the glycerol backbone of platelet-activating factor. The encoded enzyme is a subunit of the platelet-activating factor acetylhydrolase isoform 1B complex, which consists of the catalytic beta and gamma subunits and the regulatory alpha subunit. This complex functions in brain development. A translocation between this gene on chromosome 19 and the CDC-like kinase 2 gene on chromosome 1 has been observed, and was associated with cognitive disability, ataxia, and atrophy of the brain. Alternatively spliced transcript variants have been described.
- Molecular Weight
-
Observed_MW: Refer to figures
Calculated_MW: 26 kDa
- UniProt
- Q15102
-